BIOMAT Database Logo BIOMAT Database Logo

2'-substituted chalcone derivatives as inhibitors of interleukin-1 biosynthesis. 1993

D G Batt, and R Goodman, and D G Jones, and J S Kerr, and L R Mantegna, and C McAllister, and R C Newton, and S Nurnberg, and P K Welch, and M B Covington
Inflammatory Diseases Research, Du Pont Merck Pharmaceutical Co., Wilmington, Delaware 19880-0353.

A series of 2'-substituted chalcone derivatives has been found to show potent inhibition of the production of IL-1 beta from human peripheral blood monocytes stimulated with lipopolysaccharide (LPS), with IC50 values in the 0.2-5.0-microM range. Some members of the series have also shown inhibition of septic shock induced in mice by injection of LPS, although with low potency. Qualitative structure-activity relationships have shown that the enone is required for activity, which may be mediated by conjugate addition of a biological nucleophile to the chalcone. Electron-poor aromatic rings beta to the ketone give enhanced potency. Although electronic effects in the other ring (directly attached to the ketone) are minimal, this ring must possess an ortho substituent for good activity without cytotoxicity, suggesting a degree of selectivity which would not be expected for simple, nonspecific alkylating agents.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002599 Chalcone An aromatic KETONE that forms the core molecule of CHALCONES. Benzalacetophenone,Benzylideneacetophenone,1,3-Diphenyl-2-Propen-1-One,Chalkone,1,3 Diphenyl 2 Propen 1 One
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012772 Shock, Septic Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status. Endotoxin Shock,Septic Shock,Shock, Endotoxic,Shock, Toxic,Toxic Shock,Toxic Shock Syndrome,Endotoxin Shocks,Shock Syndrome, Toxic,Shock, Endotoxin,Shocks, Endotoxin,Toxic Shock Syndromes

Related Publications

D G Batt, and R Goodman, and D G Jones, and J S Kerr, and L R Mantegna, and C McAllister, and R C Newton, and S Nurnberg, and P K Welch, and M B Covington
18-Substituted progesterone derivatives as inhibitors of aldosterone biosynthesis.
July 1989, Journal of steroid biochemistry,
D G Batt, and R Goodman, and D G Jones, and J S Kerr, and L R Mantegna, and C McAllister, and R C Newton, and S Nurnberg, and P K Welch, and M B Covington
Reactive 5'-substituted 2',5'-dideoxyuridine derivatives as potential inhibitors of nucleotide biosynthesis.
May 1987, Journal of medicinal chemistry,
D G Batt, and R Goodman, and D G Jones, and J S Kerr, and L R Mantegna, and C McAllister, and R C Newton, and S Nurnberg, and P K Welch, and M B Covington
7 alpha-substituted derivatives of androstenedione as inhibitors of estrogen biosynthesis.
June 1985, Journal of medicinal chemistry,
D G Batt, and R Goodman, and D G Jones, and J S Kerr, and L R Mantegna, and C McAllister, and R C Newton, and S Nurnberg, and P K Welch, and M B Covington
Reactive 5'-substituted thymidine derivatives as potential inhibitors of nucleotide biosynthesis.
June 1986, Journal of medicinal chemistry,
D G Batt, and R Goodman, and D G Jones, and J S Kerr, and L R Mantegna, and C McAllister, and R C Newton, and S Nurnberg, and P K Welch, and M B Covington
Discovery and development of substituted tyrosine derivatives as Bcl-2/Mcl-1 inhibitors.
September 2018, Bioorganic & medicinal chemistry,
D G Batt, and R Goodman, and D G Jones, and J S Kerr, and L R Mantegna, and C McAllister, and R C Newton, and S Nurnberg, and P K Welch, and M B Covington
Biological evaluation of 5-substituted pyrimidine derivatives as inhibitors of brassinosteroid biosynthesis.
April 2001, Bioscience, biotechnology, and biochemistry,
D G Batt, and R Goodman, and D G Jones, and J S Kerr, and L R Mantegna, and C McAllister, and R C Newton, and S Nurnberg, and P K Welch, and M B Covington
3-Substituted indolizine-1-carbonitrile derivatives as phosphatase inhibitors.
January 2006, Bioorganic & medicinal chemistry letters,
D G Batt, and R Goodman, and D G Jones, and J S Kerr, and L R Mantegna, and C McAllister, and R C Newton, and S Nurnberg, and P K Welch, and M B Covington
Epsilon substituted lysinol derivatives as HIV-1 protease inhibitors.
July 2010, Bioorganic & medicinal chemistry letters,
D G Batt, and R Goodman, and D G Jones, and J S Kerr, and L R Mantegna, and C McAllister, and R C Newton, and S Nurnberg, and P K Welch, and M B Covington
Synthesis and evaluation of C3 substituted chalcone-based derivatives of 7-azaindole as protein kinase inhibitors.
December 2020, Chemical biology & drug design,
D G Batt, and R Goodman, and D G Jones, and J S Kerr, and L R Mantegna, and C McAllister, and R C Newton, and S Nurnberg, and P K Welch, and M B Covington
Novel 1-(7-ethoxy-1-benzofuran-2-yl) substituted chalcone derivatives: Synthesis, characterization and anticancer activity.
August 2017, European journal of medicinal chemistry,
Copied contents to your clipboard!